KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8

W. Zhang, S. Hong, K. P. Maniar, S. Cheng, C. Jie, A. W. Rademaker, A. M. Krensky, C. Clayberger

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

High-risk strains of human papillomavirus (HPV) are the causative agents of cervical and anogenital cancers and are associated with 5% of all human cancers. Although prophylactic vaccines targeting a subset of HPV types are available, they are ineffective in HPV-infected individuals. Elucidation of the mechanisms controlling HPV replication may allow development of novel anti-HPV therapeutics. Infectious HPV virions are produced during terminal differentiation of host cells. The process of viral maturation requires synergistic interactions between viral and cellular proteins that leads to amplification of the viral genome and expression of late viral genes. Here we show that the transcription factor Kruppel-like factor 13 (KLF13) has a critical role in the HPV life cycle. KLF13 is overexpressed in HPV-positive keratinocytes and cervical cancer cell lines. Expression of KLF13 in normal cervical epithelium is low but increases significantly in cervical intraepithelial neoplasia and invasive squamous cervical cancer. After HPV infection, the E7 protein suppresses ubiquitin ligase FBW7 expression leading to an increase in KLF13 expression. Reduction of KLF13 with short hairpin RNA in differentiating HPV-positive cells resulted in diminished levels of viral gene expression and genome amplification. Knockdown of KLF13 also reduced the level of the transcription factor signal transducer and activator of transcription 5, which led to the downregulation of the ataxia-Telangiectasia mutated DNA damage pathway and the chemokine interleukin-8 (IL-8). In addition, neutralization of IL-8 diminished viral genome amplification in differentiating HPV-positive cells. Thus, KLF13 is critical for the activation of the HPV productive life cycle and is likely involved in initiation and progression of cervical cancer.

Original languageEnglish (US)
Pages (from-to)5565-5575
Number of pages11
JournalOncogene
Volume35
Issue number42
DOIs
StatePublished - Oct 20 2016

Fingerprint

Kruppel-Like Transcription Factors
Life Cycle Stages
Interleukin-8
Keratinocytes
Uterine Cervical Neoplasms
Viral Genome
Viral Genes
Transcription Factors
STAT5 Transcription Factor
Ataxia Telangiectasia
Cervical Intraepithelial Neoplasia
Ubiquitin-Protein Ligases
Papillomavirus Infections
Viral Proteins
Chemokines
Virion

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Zhang, W., Hong, S., Maniar, K. P., Cheng, S., Jie, C., Rademaker, A. W., ... Clayberger, C. (2016). KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8. Oncogene, 35(42), 5565-5575. https://doi.org/10.1038/onc.2016.97

KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8. / Zhang, W.; Hong, S.; Maniar, K. P.; Cheng, S.; Jie, C.; Rademaker, A. W.; Krensky, A. M.; Clayberger, C.

In: Oncogene, Vol. 35, No. 42, 20.10.2016, p. 5565-5575.

Research output: Contribution to journalArticle

Zhang, W, Hong, S, Maniar, KP, Cheng, S, Jie, C, Rademaker, AW, Krensky, AM & Clayberger, C 2016, 'KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8', Oncogene, vol. 35, no. 42, pp. 5565-5575. https://doi.org/10.1038/onc.2016.97
Zhang, W. ; Hong, S. ; Maniar, K. P. ; Cheng, S. ; Jie, C. ; Rademaker, A. W. ; Krensky, A. M. ; Clayberger, C. / KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8. In: Oncogene. 2016 ; Vol. 35, No. 42. pp. 5565-5575.
@article{0b2646623dc246a8b9ef81c31b99816a,
title = "KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8",
abstract = "High-risk strains of human papillomavirus (HPV) are the causative agents of cervical and anogenital cancers and are associated with 5{\%} of all human cancers. Although prophylactic vaccines targeting a subset of HPV types are available, they are ineffective in HPV-infected individuals. Elucidation of the mechanisms controlling HPV replication may allow development of novel anti-HPV therapeutics. Infectious HPV virions are produced during terminal differentiation of host cells. The process of viral maturation requires synergistic interactions between viral and cellular proteins that leads to amplification of the viral genome and expression of late viral genes. Here we show that the transcription factor Kruppel-like factor 13 (KLF13) has a critical role in the HPV life cycle. KLF13 is overexpressed in HPV-positive keratinocytes and cervical cancer cell lines. Expression of KLF13 in normal cervical epithelium is low but increases significantly in cervical intraepithelial neoplasia and invasive squamous cervical cancer. After HPV infection, the E7 protein suppresses ubiquitin ligase FBW7 expression leading to an increase in KLF13 expression. Reduction of KLF13 with short hairpin RNA in differentiating HPV-positive cells resulted in diminished levels of viral gene expression and genome amplification. Knockdown of KLF13 also reduced the level of the transcription factor signal transducer and activator of transcription 5, which led to the downregulation of the ataxia-Telangiectasia mutated DNA damage pathway and the chemokine interleukin-8 (IL-8). In addition, neutralization of IL-8 diminished viral genome amplification in differentiating HPV-positive cells. Thus, KLF13 is critical for the activation of the HPV productive life cycle and is likely involved in initiation and progression of cervical cancer.",
author = "W. Zhang and S. Hong and Maniar, {K. P.} and S. Cheng and C. Jie and Rademaker, {A. W.} and Krensky, {A. M.} and C. Clayberger",
year = "2016",
month = "10",
day = "20",
doi = "10.1038/onc.2016.97",
language = "English (US)",
volume = "35",
pages = "5565--5575",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "42",

}

TY - JOUR

T1 - KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8

AU - Zhang, W.

AU - Hong, S.

AU - Maniar, K. P.

AU - Cheng, S.

AU - Jie, C.

AU - Rademaker, A. W.

AU - Krensky, A. M.

AU - Clayberger, C.

PY - 2016/10/20

Y1 - 2016/10/20

N2 - High-risk strains of human papillomavirus (HPV) are the causative agents of cervical and anogenital cancers and are associated with 5% of all human cancers. Although prophylactic vaccines targeting a subset of HPV types are available, they are ineffective in HPV-infected individuals. Elucidation of the mechanisms controlling HPV replication may allow development of novel anti-HPV therapeutics. Infectious HPV virions are produced during terminal differentiation of host cells. The process of viral maturation requires synergistic interactions between viral and cellular proteins that leads to amplification of the viral genome and expression of late viral genes. Here we show that the transcription factor Kruppel-like factor 13 (KLF13) has a critical role in the HPV life cycle. KLF13 is overexpressed in HPV-positive keratinocytes and cervical cancer cell lines. Expression of KLF13 in normal cervical epithelium is low but increases significantly in cervical intraepithelial neoplasia and invasive squamous cervical cancer. After HPV infection, the E7 protein suppresses ubiquitin ligase FBW7 expression leading to an increase in KLF13 expression. Reduction of KLF13 with short hairpin RNA in differentiating HPV-positive cells resulted in diminished levels of viral gene expression and genome amplification. Knockdown of KLF13 also reduced the level of the transcription factor signal transducer and activator of transcription 5, which led to the downregulation of the ataxia-Telangiectasia mutated DNA damage pathway and the chemokine interleukin-8 (IL-8). In addition, neutralization of IL-8 diminished viral genome amplification in differentiating HPV-positive cells. Thus, KLF13 is critical for the activation of the HPV productive life cycle and is likely involved in initiation and progression of cervical cancer.

AB - High-risk strains of human papillomavirus (HPV) are the causative agents of cervical and anogenital cancers and are associated with 5% of all human cancers. Although prophylactic vaccines targeting a subset of HPV types are available, they are ineffective in HPV-infected individuals. Elucidation of the mechanisms controlling HPV replication may allow development of novel anti-HPV therapeutics. Infectious HPV virions are produced during terminal differentiation of host cells. The process of viral maturation requires synergistic interactions between viral and cellular proteins that leads to amplification of the viral genome and expression of late viral genes. Here we show that the transcription factor Kruppel-like factor 13 (KLF13) has a critical role in the HPV life cycle. KLF13 is overexpressed in HPV-positive keratinocytes and cervical cancer cell lines. Expression of KLF13 in normal cervical epithelium is low but increases significantly in cervical intraepithelial neoplasia and invasive squamous cervical cancer. After HPV infection, the E7 protein suppresses ubiquitin ligase FBW7 expression leading to an increase in KLF13 expression. Reduction of KLF13 with short hairpin RNA in differentiating HPV-positive cells resulted in diminished levels of viral gene expression and genome amplification. Knockdown of KLF13 also reduced the level of the transcription factor signal transducer and activator of transcription 5, which led to the downregulation of the ataxia-Telangiectasia mutated DNA damage pathway and the chemokine interleukin-8 (IL-8). In addition, neutralization of IL-8 diminished viral genome amplification in differentiating HPV-positive cells. Thus, KLF13 is critical for the activation of the HPV productive life cycle and is likely involved in initiation and progression of cervical cancer.

UR - http://www.scopus.com/inward/record.url?scp=84962094438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962094438&partnerID=8YFLogxK

U2 - 10.1038/onc.2016.97

DO - 10.1038/onc.2016.97

M3 - Article

C2 - 27041562

AN - SCOPUS:84962094438

VL - 35

SP - 5565

EP - 5575

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 42

ER -